hospital setting News
-
Repositioning From IV to Vial-Based SC for Large-Volume Biologics
Our expert discusses the growing trend of moving away from intravenous drugs administered in clinical and hospital settings to at-home, self-administered vial-based subcutaneous delivery for cost savings, better lifecycle management and improved care. Learn more about our technology by reading the latest article in On Drug ...
By Sonceboz SA
-
Sense announces strategic collaboration with healthcare catalyst Inflect Health
Sense Neuro Diagnostics, a medical technology company focused on improving outcomes for stroke and brain injury patients, today announced a strategic collaboration with Inflect Health, the new nationwide, multispecialty investment and innovation hub formed by Vituity. As part of this new relationship, Inflect Health will provide Sense access to its robust network of frontline physicians and ...
-
Clinical investigations
We performed 2 clinical trials in leading neurorehabilitation hospitals in Germany and Spain proving safety, feasibility and usability of the exoskeleton in a clinical setting, and showing significant improvements in clinical outcomes and benefits in rehabilitation. A Multicentric Clinical investigation in Institut Guttmann (Spain) and Heidelberg University Hospital (Germany), leading European ...
-
Presentation at ECCMID
Synairgen plc (LSE: SNG), the respiratory company developing SNG001, an investigational formulation for inhalation containing the broad-spectrum antiviral protein interferon beta, presented the sub-group analysis from its Phase 2, SG016 study on Saturday 23 April in an oral presentation at the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), held in Lisbon, ...
-
ClearPoint Neuro Congratulates Blackrock Neurotech on Receiving Breakthrough Device Designation from the FDA for the MoveAgain Brain-Computer Interface System
ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today congratulates partner Blackrock Neurotech for receiving Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its groundbreaking MoveAgain Brain Computer Interface (BCI) system. There are an estimated ...
-
How BioVigil Reduces Staff Absenteeism in Hospitals
Staff absences are a problem for any employer, but are particularly challenging in hospitals and other healthcare settings. Unplanned staff absences can leave supervisors struggling to fill shifts and overwork employees who have to cover for their peers. These drops in productivity or gaps in care can put patients at risk. To combat employee absenteeism and its effects, hospitals need to ...
By BioVigil
-
RevMedx receives CE Mark for XSTAT® injectable hemostatic devices
Revolutionary bleeding control technology will now be available in Europe and other International markets. RevMedx, Inc., a leader in innovative devices that control severe bleeding, today announced it has received CE (Conformité Européenne) Mark Certification for the XSTAT 30 and XSTAT 12 hemostatic devices in Europe. Unlike traditional wound treatments that may take several ...
By RevMedx
-
S.F.-based startup raises $25M to expand blood collection technologies
San Francisco medical device company Velano Vascular closed a $25 million second round of financing, bringing its total overall to $50 million. The new capital will go toward expanding its needle-less blood draw device and to developing new technologies. CEO Eric Stone would not reveal what these new technologies will entail but said they will fall within the company’s mission ...
-
RevMedx announces adoption of XSTAT gunshot wound treatment by emergency responders in Highland Park, Texas
RevMedx, Inc. announced today that the Highland Park Department of Public Safety (Highland Park, TX) is fielding XSTAT as a new treatment option in their medical and trauma kits. Located three miles north of Dallas, Highland Park Department of Public Safety works closely with other Dallas Metro services including Dallas Fire and Rescue and University Park Fire Department on Automatic Assistance ...
By RevMedx
-
RevMedx receives CE Mark for XGAUZE® self-expanding gauze.
Manufacturer of the revolutionary XSTAT technology will now have a second sterile wound dressing available in Europe and other International markets. RevMedx, Inc., a global leader in innovative devices that control severe bleeding, today announced it has received CE (Conformité Européenne) Mark Certification for the XGAUZE wound dressing in Europe. XGAUZE, a Class I sterile ...
By RevMedx
-
Cone Health using radar technology to better treat heart failure
Congestive heart failure is one of the most common reasons elderly people end up in the hospital. When this happens fluid builds up in the lungs and patients have trouble breathing. Cone Health is the first in the country to use a new technology to measure the amount of fluid in the lungs in the inpatient hospital setting. “Now we have a device that lets us know in 90 seconds whether there ...
-
Vaxdyn introduces its multi-pathogen vaccine candidate KapaVax at the World Vaccine Congress Europe
In an oral presentation within the track “AMR & Bacterial Vaccines”, chaired by Dr Jan Poolman (Bacterial Vaccine Discovery and Early Development, Janssen), Dr. Infante showed how Vaxdyn’s technology can deliver endotoxin-free inactivated whole cell vaccines presenting outer-membrane proteins of different bacteria in the surface, therefore raising immunity against ...
-
A project led by Vaxdyn receives funding from Next Generation EU Funds
The project “AMReady: Development and manufacturing of vaccines for alleviation and preparedness for anti-microbial resistance global health crisis”, to be executed in 2021-2024 with a total budget of 1.4 million euro has been awarded funding by the competitive program Lineas Estratégicas de Colaboración Público-Privada 2021 of the State Research Agency of the ...
-
LOK Corporation and Sense Neuro Diagnostics Announce Commercial Partnership Focused on International Market
(August 17, 2021—Montreal, Canada and Cincinnati, Ohio) LOK Corporation, a manufacturing agent that helps companies develop and manage their international distribution network and Sense Neuro Diagnostics, a medical technology company focused on improving outcomes for stroke and brain injury patients today announced a commercial partnership to bring innovative brain scanners being developed ...
-
Hospitals Battle Healthcare Acquired Infections (HAIs)
An article in the August issue of Infection Control and Hospital Epidemiology discusses how researchers identified contaminated nasal spray as the cause of an outbreak of Burkholderia cepacia in patients at a Denver children’s hospital. A recent news story from WLWT last week reported on the source of a Legionnaires’ disease outbreak at an Ohio hospital in 2010. WHEC in New York ...
-
Sekisui Diagnostics Announces Launch of The Osom® Ultra Plus Flu A&B Test in Europe
High performance, point-of-care rapid test for the detection of Influenza A&B Burlington, MA – November 17, 2020 –SEKISUI Diagnostics announces it has received CE Marking (Conformité Européenne) for the OSOM® Ultra Plus Flu A&B Test and has begun marketing in Europe. The test utilizes traditional lateral flow technology with performance near or exceeding ...
-
ELITechGroup Molecular Diagnostics announce the CE-IVD marking of the CRE ELITe MGB Kit, for the detection of the Carbapenem Resistance genes of Enterobacteriaceae
ELITechGroup Molecular Diagnostics announce today the CE-IVD marking of the CRE ELITe MGB kit, a high-performance, qualitative, multiplex assay for the rapid detection of the Carbapenem Resistance genes of Enterobacteriaceae. In combination with the ELITe InGenius™, the ELITech Group’s fully automated sample-to-result system, the assay is intended to detect 150 variants belonging to ...
By ELITechGroup
-
FDA Bans Use Of Triclosan In Health Care Antiseptics
At the end of last year, the U.S. Food and Drug Administration (FDA) banned 24 ingredients commonly used in over-the-counter (OTC) topical antiseptics. These active ingredients – which are now no longer ‘generally recognized as safe and effective’ – include triclosan, an antibacterial and antifungal agent found in many consumer and health care products. Background ...
-
Rex Medical Completes Patient Enrollment for the REVEAL Peripheral Atherectomy U.S. Trial
CONSHOHOCKEN, Pa. Mar. 19, 2019 --(BUSINESS WIRE)--Rex Medical, L.P., a medical device design and development company, today announced the successful completion of enrollment in the Revolution™ Peripheral Atherectomy System for Lower Extremity Peripheral Arterial Revascularization (REVEAL) IDE clinical trial. The REVEAL trial is a single arm, prospective study to evaluate the safety ...
-
Sense receives clearance to expand ongoing clinical trial to evaluate non-invasive brain scanner to sites in India and Canada
Clinical trial underway at five US hospital sites to evaluate Sense’s novel, non-invasive brain scanner to monitor intracranial hemorrhage in acute hospital setting Drug Controller General of India (DCGI) and Health Canada grant permission to conduct clinical trial at multiple sites in India and Canada Current standard of care lacks a means to monitor brain injury continuously, ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you